| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 03/01/2001 | CA2376406A1 G protein-coupled receptor expressed in brain |
| 03/01/2001 | CA2344469A1 Pesticidal proteins |
| 02/28/2001 | EP1078266A1 HUMAN CHROMOGRANIN A (GgA) IMMUNOLOGIC ASSAY, ANTIBODIES, REAGENTS AND KITS FOR SAID ASSAY |
| 02/28/2001 | EP1078082A1 Enzymatically-active recombinant human beta-tryptase and method of making same |
| 02/28/2001 | EP1078081A2 Methods for producing heterologous polypeptides in trichothecene-deficient filamentous fungal mutant cells |
| 02/28/2001 | EP1078080A1 Methods for producing polypeptides in filamentous fungal mutant cells |
| 02/28/2001 | EP1078076A2 Novel nucleic acids and polypeptides related to a farnesyl-directed endopeptidase |
| 02/28/2001 | EP1078073A1 Chitinase chitin-binding fragments |
| 02/28/2001 | EP1078072A1 New peptide fragments for protein purification |
| 02/28/2001 | EP1078064A2 Compounds from moraxella catarrhalis |
| 02/28/2001 | EP1078063A2 Basb029polynucleotide(s) and polypeptides from neisseria meningitis |
| 02/28/2001 | EP1078060A2 Antibodies to dendritic cells and human dendritic cell populations and uses thereof |
| 02/28/2001 | EP1078057A2 Cell signaling proteins |
| 02/28/2001 | EP1078056A1 Rhotekin, a putative target for rho |
| 02/28/2001 | EP1078054A1 Monomer protein with bone morphogenetic activity and medicinal agent containing the same for preventing and treating diseases of cartilage and bone |
| 02/28/2001 | EP1078052A2 Noncloning technique for expressing a gene of interest |
| 02/28/2001 | EP1078046A1 97 human secreted proteins |
| 02/28/2001 | EP1078040A1 Nt2lp, novel g-protein coupled receptors having homology to neurotensin-2 receptors |
| 02/28/2001 | EP1078006A1 Diagnosis and treatment of hepatic disorders |
| 02/28/2001 | EP1078005A1 Methods for amyloid removal using anti-amyloid antibodies |
| 02/28/2001 | EP1077999A2 Moraxella catharralis proteins |
| 02/28/2001 | EP1077996A1 HUMAN EDG3sb GENE |
| 02/28/2001 | EP1077991A1 Secreted proteins and polynucleotides encoding them |
| 02/28/2001 | EP1077989A1 Tumor associated antigen encoded by the reverse strand of a new ubiquitously expressed gene |
| 02/28/2001 | EP1077983A2 Pria |
| 02/28/2001 | EP0672142B1 Multivalent and multispecific binding proteins, their manufacture and use |
| 02/28/2001 | EP0594710B1 Tyrosine kinase |
| 02/28/2001 | EP0584284B1 Recombinant dna-derived cholera toxin subunit analogs |
| 02/28/2001 | EP0548165B1 Expression of g protein coupled receptors in yeast |
| 02/28/2001 | CN1285846A Detection systems for registering protein interactions and functional relationships |
| 02/28/2001 | CN1285514A Medicine box bof testing anti-hepatitis C virus antibody |
| 02/28/2001 | CN1285405A Human RIP 110 protein and code sequence thereof |
| 02/28/2001 | CN1285404A Human sarcosine oxidase and code sequence thereof |
| 02/28/2001 | CN1062605C Process for preparation of Escherichia coli vaccine |
| 02/28/2001 | CN1062600C Process for preparation selenic antibody enzyme |
| 02/28/2001 | CN1062565C Recombinating haman alpha type composite interferon and preparation process and use thereof |
| 02/27/2001 | US6194560 Synthetic escherichia coli gene which encodes lt-b; the dna sequence is optimized for plant codon usage; feeds; foods |
| 02/27/2001 | US6194551 Polypeptide variants |
| 02/27/2001 | US6194549 Partially purified preparation of pen5, a glycoprotein pair; for detecting and/or removing natural killer cells from a mixed population of cells |
| 02/27/2001 | US6194546 Influenza virus haemagglutinin which has a heterologous epitope at antigenic site a; vaccines against foot-and-mouth disease, poliovirus, human rhinovirus, hepatitis b virus, plasmodium and bacteria |
| 02/27/2001 | US6194542 Method of detecting cytomegalovirus (CMV) |
| 02/27/2001 | US6194385 Calcium-binding protein |
| 02/27/2001 | US6194383 Homologous cyclic amino-acid sequences having different fatty acid residues synthesized by actinoplanes sp.; peptide antibiotics, lipopeptides a 1437, a-m, effective against grampositive bacteria and glycopeptide-resistant strains |
| 02/27/2001 | US6194190 From pyrococcus which can release two or more blocking groups selected from acetyl group, pyroglutamyl group, formyl group and myristoyl group, from protected peptides; use in kits for analyzing an amino acid sequence |
| 02/27/2001 | US6194188 Type II restriction endonuclease, HpyCH4IV, obtainable from Helicobacter pylori CH4 and a process for producing the same |
| 02/27/2001 | US6194187 Apoptosis-inducing protein and gene encoding the same |
| 02/27/2001 | US6194186 Human protein kinase and kinase inhibitors |
| 02/27/2001 | US6194177 DNA encoding a hybrid heterodimeric protein |
| 02/27/2001 | US6194172 Cytokine designated lerk-6 |
| 02/27/2001 | US6194171 Also vectors, transformed cells; useful for expression in cells for the purposes of identifying agonists or antagonists of ataxin-2-binding protein function |
| 02/27/2001 | US6194166 Isolated dna; genetic engineering |
| 02/27/2001 | US6194162 Method of screening for compounds that bind P2x receptor |
| 02/27/2001 | US6194156 Isolated nucleic acid molecules which encode TAGE molecules, and uses thereof |
| 02/27/2001 | US6194152 Nucleotide sequences for the diagnosis and treatment of human urogenital cancers |
| 02/27/2001 | US6194151 Nucleotide sequences coding binding polypeptide; for the detection of modulators of tumor necrosis factor activity; for the treatment of cell proliferation and differentiation defects |
| 02/27/2001 | US6193982 Anti-cyanovirin antibody with an internal image of gp120, a method of use thereof, and a method of using a cyanovirin to induce an immune response to gp120 |
| 02/27/2001 | US6193981 Methods and compositions for impairing multiplication of HIV-1 |
| 02/27/2001 | US6193972 Hybrid heterodimeric protein hormone |
| 02/27/2001 | US6193969 Preventing, ameliorating, or treating septic shock or its symptoms by administering igg (immunoglobulin g) fab fragments reactive towards tnf.alpha.(tumor nercosis factor), wherein igg fab fragments are derived from polyclonal igg |
| 02/27/2001 | US6193967 Administering bispecific molecule, comprising: binding specificity for human high density lipoprotein (hdl), or fragment and for an fc.gamma. receptor for immunoglobulin g for treating and prophylaxis of atherosclerosis |
| 02/27/2001 | US6193966 Administering bispecific protein or peptide molecule, comprising a first binding determinate which binds to fc.alpha.receptor without being blocked by immunoglobulin a and second binding determinant which binds to target antigen |
| 02/27/2001 | US6193965 Administering therapeutically effective amount of reagent which modulates kinase activity for treating cell proliferative disorder associated with c-jun n-terminal kinase disorder, |
| 02/27/2001 | US6193963 Method of treating tumor-bearing patients with human plasma hyaluronidase |
| 02/27/2001 | CA2232789C Method for treating alzheimer's disease using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 02/27/2001 | CA2025598C Chimaeric hepadnavirus core antigen proteins |
| 02/27/2001 | CA1341192C Process for the preparation of a protein by yeasts using an inducible system, corresponding vectors and transformed strains |
| 02/27/2001 | CA1341191C Detection of neu gene expression and products |
| 02/27/2001 | CA1341190C Process for the integration of a chosen gene into a chromosome of a bacteria, and bacteria obtained by the process |
| 02/22/2001 | WO2001012836A1 Crystal of a truncated protein construct containing a coagulation factor viii c2 domain in the presence or absence of a bound ligand and methods of use thereof |
| 02/22/2001 | WO2001012820A1 Genetic system and self-cleaving inteins derived therefrom, bioseparations and protein purification employing same, and methods for determining critical, generalizable amino acid residues for varying intein activity |
| 02/22/2001 | WO2001012811A1 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| 02/22/2001 | WO2001012807A1 MODIFIED cDNA OF RAT bcl-x GENE AND MODIFIED PROTEIN |
| 02/22/2001 | WO2001012805A1 Methods for diagnosis and treatment of human diseases including hypertension |
| 02/22/2001 | WO2001012786A1 Retinoid receptor interacting polynucleotides, polypeptides, and antibodies |
| 02/22/2001 | WO2001012781A1 13 human colon and colon cancer associated proteins |
| 02/22/2001 | WO2001012776A2 18 human secreted proteins |
| 02/22/2001 | WO2001012775A2 25 human secreted proteins |
| 02/22/2001 | WO2001012674A1 Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof |
| 02/22/2001 | WO2001012673A1 Pgpcr-3 polypeptides and dna sequences thereof |
| 02/22/2001 | WO2001012672A2 Cytokine receptor common gamma chain like |
| 02/22/2001 | WO2001012671A1 Human tumor necrosis factor receptor tr16 |
| 02/22/2001 | WO2001012670A1 Tgf-beta receptor polynucleotides, polypeptides, and antibodies |
| 02/22/2001 | WO2001012665A2 Helical cytokine zalpha48 |
| 02/22/2001 | WO2001012664A2 Notch receptor ligands and uses thereof |
| 02/22/2001 | WO2001012662A2 Membrane associated proteins |
| 02/22/2001 | WO2001012652A1 fabF |
| 02/22/2001 | WO2001012648A1 Novel transcription factor, bp1 |
| 02/22/2001 | WO2001012172A1 Treatment of metastatic disease |
| 02/22/2001 | WO2000077179A3 Human poly(adp-ribose) polymerase 2 materials and methods |
| 02/22/2001 | WO2000061761A3 Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines |
| 02/22/2001 | WO2000058483A3 Protozoan expression system |
| 02/22/2001 | WO2000055633A3 Methods of screening for colorectal cancer modulators |
| 02/22/2001 | WO2000043521A3 Endogenetic nucleic fragment associated with an autoimmune disease, marking method and reagent |
| 02/22/2001 | WO2000039297A3 Il-1 related polypeptides |
| 02/22/2001 | WO1999047553A3 Bacterial yeal family members as targets for antimicrobial drug design |
| 02/22/2001 | DE19939578A1 New nucleic acid encoding hemocyanin, useful for gene therapy of tumors and for recombinant production of fusion proteins for vaccination |
| 02/22/2001 | DE19939246A1 Refolding membrane proteins into their native or active form comprises solubilizing the protein in a first detergent and replacing the first detergent with a second detergent |
| 02/22/2001 | CA2385487A1 13 human colon and colon cancer associated proteins |
| 02/22/2001 | CA2385475A1 18 human secreted proteins |
| 02/22/2001 | CA2385431A1 Tgf-beta receptor polynucleotides, polypeptides, and antibodies |